Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2022-12-01 | New | $6,000,002 | $6,000,002 | Equity Only | 06b | SEC link |
| 2022-12-01 | Amended | $6,000,002 | $0 | Equity Only | 06b | SEC link |
| 2022-01-20 | New | $15,902,341 | $15,902,341 | Equity Only | 06b | SEC link |
| 2020-11-12 | New | $25,799,973 | $25,799,973 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Philip A. Barach | Director, Executive |
| David Friedman | Director |
| Steven N. Gordon | Director, Executive |
| Francois Maisonrouge | Director |
| Joel Marcus | Director |
| Christina Ramirez | Director |
| Peter M. Simon | Director |
| Christopher Thorn | Executive |
| Samuel Waksal | Director, Executive |
| Sam Waksal | Executive |